To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Surgical and not analgesic technique affects postoperative inflammation following colorectal cancer surgery: a prospective, randomized study
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Anesthesiology and Intensive Care, Örebro University Hospital, Örebro, Sweden.
Department of Anesthesiology and Intensive care, County Council of Östergötland, Linköping, Sweden.
School of Medical Sciences, Örebro University, Örebro, Sweden. (Clinical Epidemiology and Biostatistics)
Cell and Experimental Pathology, Department of Translational Medicine, Lund University, Malmö, Sweden.
Vise andre og tillknytning
2017 (engelsk)Inngår i: Colorectal Disease, ISSN 1462-8910, E-ISSN 1463-1318, Vol. 19, nr 6, s. O186-O195Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

AIM: Epidural analgesia reduces the surgical stress response. However, its effect on pro- and anti-inflammatory cytokines in the genesis of inflammation following major abdominal surgery remains unclear. Our main objective was to elucidate whether perioperative epidural analgesia prevents the inflammatory response following colorectal cancer surgery.

METHODS: 96 patients scheduled for open or laparoscopic surgery were randomized to epidural analgesia (group E) or patient controlled intravenous analgesia (group P). Surgery and anaesthesia were standardized in both groups. Plasma cortisol, insulin and serum cytokines (IL-1β,IL-4,IL-5,IL-6,IL-8,IL-10,IL-12p70,IL-13,TNFα,IFNγ,GM-CSF,PGE2 and VEGF) were measured preoperatively (T0), 1-6 hours postoperatively (T1) and 3-5 days postoperatively (T2). Mixed model analysis was used, after logarithmic transformation when appropriate, for analyses of cytokines and stress markers.

RESULTS: There were no significant differences in any serum cytokine concentration between groups P and E at any time point except in IL-10 which was 87% higher in group P (median and range 4.1 (2.3-9.2) pg/ml,) compared to group E (2.6 (1.3-4.7) pg/ml) (p=0.002) at T1. There was no difference in plasma cortisol and insulin between the groups at any time point after surgery. Significant difference in median serum cytokine concentration was found between open and laparoscopic surgery with higher levels of IL-6,IL-8 and IL-10 at T1 in patients undergoing open surgery compared to laparoscopic surgery. No difference in serum cytokine concentration was detected between the groups or between the surgical technique at T2.

CONCLUSIONS: Open surgery, compared to laparoscopic surgery, has greater impact on these inflammatory mediators than epidural analgesia vs. intravenous analgesia. This article is protected by copyright. All rights reserved.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2017. Vol. 19, nr 6, s. O186-O195
Emneord [en]
Anaesthesia, epidural, surgery, colorectal cancer, inflammation, cytokines
HSV kategori
Forskningsprogram
Onkologi; Kirurgi; Anestesiologi
Identifikatorer
URN: urn:nbn:se:oru:diva-57387DOI: 10.1111/codi.13643ISI: 000402674400003PubMedID: 28258664Scopus ID: 2-s2.0-85018758511OAI: oai:DiVA.org:oru-57387DiVA, id: diva2:1092732
Merknad

Funding Agency:

Regional Research Committee, Örebro-Uppsala Region, Sweden

Tilgjengelig fra: 2017-05-03 Laget: 2017-05-03 Sist oppdatert: 2022-02-11bibliografisk kontrollert
Inngår i avhandling
1. Epidural Analgesia for Colorectal Cancer Surgery: Experimental and Clinical studies
Åpne denne publikasjonen i ny fane eller vindu >>Epidural Analgesia for Colorectal Cancer Surgery: Experimental and Clinical studies
2021 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Abstract [en]

Epidural analgesia (EA) with local anaesthetics and opioids is used for pain management after colorectal cancer (CRC) surgery. In recent years, a possible beneficial effect of EA on cancer recurrence and survival after surgery has been proposed. The aim of this thesis was to study the effects of EA on short- and long-term postoperative outcomes after CRC surgery with curative intent.

Study I, an in vitro study, investigated the effects of two different local anaesthetics, lidocaine and ropivacaine, on cell viability and cell proliferation in colon cancer cell lines SW480 and SW620. Neither lidocaine nor ropivacaine reduced cell viability or proliferation at systemically, by epidural administration achievable concentrations.

In study II, the effect of EA on the systemic level of different cytokines as a marker of inflammation was studied. Except for a reduced level of the anti-inflammatory cytokine IL-10, no other significant effects of EA on the systemic cytokine levels at two time points postoperatively could be shown, when compared to patients receiving intravenous morphine.

Study III was an epidemiological study, examining the question if EA affects postoperative complications and mortality after surgery using data from the Swedish Colorectal Cancer Registry and the Swedish Perioperative Registry. No association between EA and a reduction in postoperative complications or mortality could be established.

Study IV, a randomised, controlled trial, the effects of EA on diseasefree survival (DFS), postoperative complications and pain after surgery were compared to patient-controlled intravenous analgesia with morphine. Apart from superior pain relief during the first postoperative day, no significant effects of EA on the occurrence of postoperative complications, length of hospital stay or DFS were found.

sted, utgiver, år, opplag, sider
Örebro: Örebro University, 2021. s. 67
Serie
Örebro Studies in Medicine, ISSN 1652-4063 ; 237
Emneord
colorectal cancer, epidural analgesia, local anaesthetics, colon cancer cells, inflammation, postoperative complications, pain, recurrence, disease-free survival, mortality
HSV kategori
Identifikatorer
urn:nbn:se:oru:diva-90317 (URN)978-91-7529-384-4 (ISBN)
Disputas
2021-06-03, Örebro universitet, Campus USÖ, hörsal C1, Södra Grev Rosengatan 32, Örebro, 09:00 (svensk)
Opponent
Veileder
Tilgjengelig fra: 2021-03-09 Laget: 2021-03-09 Sist oppdatert: 2022-02-11bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Siekmann, WiebkeMatthiessen, PeterGupta, Anil

Søk i DiVA

Av forfatter/redaktør
Siekmann, WiebkeMatthiessen, PeterGupta, Anil
Av organisasjonen
I samme tidsskrift
Colorectal Disease

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 147 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf